quinazolines has been researched along with Syndrome in 23 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (13.04) | 18.2507 |
2000's | 13 (56.52) | 29.6817 |
2010's | 6 (26.09) | 24.3611 |
2020's | 1 (4.35) | 2.80 |
Authors | Studies |
---|---|
Aboukhashaba, A; Fainberg, J; Gaffney, C; Kashanian, J; Khan, A; Pierce, H | 1 |
Baselga, J; Cortés, J; Garcia-Saenz, JA; Germa, C; Harb, W; Kiger, C; Kim, SB; Martin, M; Moroose, R; Pluard, T; Saura, C; Wang, K; Xu, B | 1 |
Gao, Y; Liu, S; Pang, Z; Yang, X; Yu, Y | 1 |
Arikan, G; Bozkurt, O; Demir, O; Durak, I; Esen, A; Saatci, AO; Yaman, A | 1 |
Mamalis, N | 1 |
Goseki, T; Ishikawa, H; Nemoto, N; Nishimoto, H; Patil, PN; Shimizu, K; Uga, S | 1 |
Descourt, R; Misery, L; Roguedas, AM; Rouxel, AM | 1 |
Afifi, Y; Benomar, S; Bouhllab, J; Boutayeb, S; Errihanni, H; Hamada, S; Hassam, B | 1 |
Chatziralli, IP; Sergentanis, TN | 1 |
Fine, HA; Floeter, MK; Iwamoto, FM; Kreisl, TN; Lehky, TJ | 1 |
Hu, MI | 1 |
Fang, Z; Li, B; Zang, YS | 1 |
Arunkalaivanan, A; Sinha, D | 1 |
Afshari, NA; Schwinn, DA | 1 |
Fitt, AW; Settas, G | 1 |
Fujita, Y; Inamura, M; Koyama, T; Miyoshi, T; Ohashi, Y; Ohki, K; Okamoto, S; Oshika, T; Sakabe, I; Takahashi, K; Yasuma, T | 1 |
Awan, MA; Cheung, CM; Peh, KK; Sandramouli, S | 1 |
Blouin, J; Blouin, MC; Dragomir, A; Lapointe, A; Perreault, S | 1 |
Chang, DF; Lluel, P; Palea, S; Regnier, A; Rekik, M | 1 |
Nickel, JC | 1 |
Rabl, W; Standl, E; Stemplinger, J; Stiegler, H; Weichenhain, B; Ziegler, AG | 1 |
Feldman, EL; Greene, DA; Stevens, MJ | 1 |
de Boo, T; de la Rosette, JJ; Debruyne, FM; Karthaus, HF; van Kerrebroeck, PE | 1 |
3 review(s) available for quinazolines and Syndrome
Article | Year |
---|---|
Risk factors for intraoperative floppy iris syndrome: a meta-analysis.
Topics: Adrenergic alpha-1 Receptor Antagonists; Diabetes Complications; Doxazosin; Humans; Hypertension; Incidence; Intraoperative Complications; Iris; Iris Diseases; Odds Ratio; Phacoemulsification; Prazosin; Quinazolines; Risk Factors; Sulfonamides; Syndrome; Tamsulosin | 2011 |
Role of alpha1-blockers in chronic prostatitis syndromes.
Topics: Adrenergic alpha-Antagonists; Anti-Infective Agents; Bacterial Infections; Chronic Disease; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Drug Therapy, Combination; Ejaculation; Humans; Male; Pelvic Pain; Prostatism; Prostatitis; Quality of Life; Quinazolines; Randomized Controlled Trials as Topic; Secondary Prevention; Syndrome | 2008 |
Diabetic neuropathy: scope of the syndrome.
Topics: Aldehyde Reductase; Animals; Chronic Disease; Controlled Clinical Trials as Topic; Diabetic Foot; Diabetic Neuropathies; Disease Progression; Enzyme Inhibitors; Humans; Neural Conduction; Prevalence; Quinazolines; Syndrome | 1999 |
3 trial(s) available for quinazolines and Syndrome
Article | Year |
---|---|
Safety and efficacy of neratinib in combination with capecitabine in patients with metastatic human epidermal growth factor receptor 2-positive breast cancer.
Topics: Administration, Oral; Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Breast Neoplasms, Male; Capecitabine; Deoxycytidine; Diarrhea; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Lapatinib; Male; Middle Aged; Neoplasm Metastasis; Paresthesia; Quinazolines; Quinolines; Receptor, ErbB-2; Syndrome; Trastuzumab; Treatment Outcome | 2014 |
Decreased urinary glycosaminoglycan excretion following alfuzosin treatment on ureteral stent-related symptoms: a prospective, randomized, placebo-controlled study.
Topics: Adult; Double-Blind Method; Female; Glycosaminoglycans; Hematuria; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prospective Studies; Quinazolines; Sexual Dysfunction, Physiological; Stents; Surveys and Questionnaires; Syndrome; Treatment Outcome; Ureter; Ureteral Calculi; Ureteral Diseases; Ureteroscopy; Urinary Bladder; Urological Agents | 2016 |
Research in 'prostatitis syndromes': the use of alfuzosin (a new alpha 1-receptor-blocking agent) in patients mainly presenting with micturition complaints of an irritative nature and confirmed urodynamic abnormalities.
Topics: Adrenergic alpha-Antagonists; Adult; Double-Blind Method; Humans; Male; Middle Aged; Prostatitis; Quinazolines; Syndrome; Urination; Urodynamics | 1992 |
17 other study(ies) available for quinazolines and Syndrome
Article | Year |
---|---|
Postorgasmic illness syndrome: potential new treatment options for a rare disorder.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Humans; Male; Orgasm; Prazosin; Quinazolines; Sexual Dysfunction, Physiological; Syndrome | 2020 |
The effect of various alpha1-adrenergic receptor antagonists on pupillary dilation.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Doxazosin; Humans; Iris Diseases; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Pupil; Quinazolines; Sulfonamides; Syndrome; Tamsulosin | 2008 |
Intraoperative floppy-iris syndrome associated with systemic alpha blockers.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Cataract Extraction; Doxazosin; Humans; Intraoperative Complications; Iris Diseases; Male; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Syndrome; Tamsulosin | 2008 |
Possible mechanism of intraoperative floppy iris syndrome: a clinicopathological study.
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Antihypertensive Agents; Female; Glaucoma; Humans; Iris Diseases; Male; Quinazolines; Syndrome | 2008 |
[Hand-foot syndrome: A new side effect of erlotinib].
Topics: Aged; Diagnosis, Differential; ErbB Receptors; Erlotinib Hydrochloride; Erythema; Foot Dermatoses; Foot Diseases; Hand Dermatoses; Humans; Lung Neoplasms; Male; Protein Kinase Inhibitors; Quinazolines; Syndrome | 2008 |
Hand-foot syndrome and seborrheic dermatitis-like eruption induced by erlotinib.
Topics: Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Dermatitis, Seborrheic; Disease Progression; Drug Eruptions; Erlotinib Hydrochloride; Facial Dermatoses; Follow-Up Studies; Hand Dermatoses; Humans; Lung Neoplasms; Male; Middle Aged; Protein Kinase Inhibitors; Quinazolines; Risk Assessment; Syndrome | 2009 |
Neuromuscular junction toxicity with tandutinib induces a myasthenic-like syndrome.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Clinical Trials, Phase II as Topic; Drug Administration Schedule; Electromyography; Female; Glioblastoma; Humans; Male; Middle Aged; Myasthenia Gravis; Neuromuscular Diseases; Neuromuscular Junction; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Quinazolines; Syndrome | 2011 |
Updates in the management of medullary thyroid cancer.
Topics: Carcinoma, Neuroendocrine; Contraindications; Humans; Multiple Endocrine Neoplasia; Mutation; Piperidines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-ret; Quinazolines; Research; Syndrome; Thyroid Neoplasms | 2011 |
Erlotinib plus parenteral nutrition: an opportunity to get through the hardest days of advanced non-small cell lung cancer with cancer anorexia-cachexia syndrome.
Topics: Anorexia; Cachexia; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Erlotinib Hydrochloride; Humans; Lung Neoplasms; Male; Middle Aged; Parenteral Nutrition; Quinazolines; Syndrome | 2013 |
Urethral syndrome: response to alpha-adrenergic blocking agents.
Topics: Adrenergic alpha-Antagonists; Adult; Depression; Female; Humans; Quinazolines; Remission Induction; Sulfonamides; Syndrome; Tamsulosin; Urinary Bladder, Overactive | 2006 |
Alpha1-adrenergic antagonists and floppy iris syndrome: tip of the iceberg?
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Doxazosin; Humans; Intraoperative Complications; Iris Diseases; Phacoemulsification; Prazosin; Pupil; Quinazolines; Sulfonamides; Syndrome; Tamsulosin | 2005 |
Intraoperative floppy iris syndrome in a patient taking alfuzosin for benign prostatic hypertrophy.
Topics: Adrenergic alpha-Antagonists; Aged, 80 and over; Cataract Extraction; Humans; Intraoperative Complications; Iris; Male; Prostatic Hyperplasia; Quinazolines; Syndrome | 2006 |
Incidence of intraoperative floppy iris syndrome in patients on either systemic or topical alpha(1)-adrenoceptor antagonist.
Topics: Administration, Topical; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Cataract Extraction; Female; Humans; Incidence; Intraoperative Complications; Iris Diseases; Male; Naphthalenes; Piperazines; Prospective Studies; Prostatic Hyperplasia; Pupil; Quinazolines; Sulfonamides; Syndrome; Tamsulosin | 2007 |
Incidence of intraoperative floppy iris syndrome in patients on either systemic or topical alpha1-adrenoceptor antagonist.
Topics: Administration, Topical; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Cataract Extraction; Doxazosin; Female; Humans; Hypertension; Incidence; Intraoperative Complications; Iris Diseases; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Pupil; Quinazolines; Sulfonamides; Syndrome; Tamsulosin | 2007 |
Intraoperative floppy-iris syndrome associated with alpha1-adrenoreceptors: comparison of tamsulosin and alfuzosin.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Humans; Incidence; Intraoperative Complications; Iris Diseases; Male; Odds Ratio; Phacoemulsification; Postoperative Complications; Prostatic Hyperplasia; Quinazolines; Retrospective Studies; Risk Factors; Sulfonamides; Syndrome; Tamsulosin | 2007 |
Comparative effect of alfuzosin and tamsulosin on the contractile response of isolated rabbit prostatic and iris dilator smooth muscles: possible model for intraoperative floppy-iris syndrome.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Intraoperative Complications; Iris; Iris Diseases; Male; Muscle, Smooth; Phenylephrine; Prostate; Quinazolines; Rabbits; Sulfonamides; Sympathomimetics; Syndrome; Tamsulosin | 2008 |
[Alström syndrome--a rare disease of diabetic association].
Topics: Adult; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diagnosis, Differential; DNA Mutational Analysis; Humans; Male; Obesity; Optic Atrophy; Quinazolines; Retinitis Pigmentosa; Second Messenger Systems; Syndrome | 1997 |